Nalaganje...
Randomized, Controlled Trial of Miglustat in Gaucher’s Disease Type 3
OBJECTIVE: To evaluate the efficacy and safety of miglustat, concomitant with enzyme replacement therapy (ERT), in patients with Gaucher’s disease type 3 (GD3). METHODS: This 24-month, phase II, open-label clinical trial of miglustat in GD3 was conducted in two phases. During the initial 12 months,...
Shranjeno v:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2008
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2605167/ https://ncbi.nlm.nih.gov/pubmed/19067373 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.21491 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|